全体要約
この研究によると、2029年までに世界の核酸医薬品市場規模は数百万米ドルに達する見込みです。
市場は製品タイプ、アプリケーション、主要プレーヤー、地域別に詳細に分析されています。製品タイプにはASO、mRNA、siRNA、miRNA、saRNA、アプタマーが含まれ、アプリケーションには遺伝病、癌、心血管疾患などがあります。
市場はアメリカ、中国、ヨーロッパ、日本、韓国、東南アジアなどの地域に分かれています。主要なプレーヤーには、アイオニス・ファーマシューティカルズ、サレプタ・セラピューティクス、ニッポン・シンヤク、バイオンテック、モデルナ・セラピューティクスなどが含まれています。
関連する質問
Ionis Pharmaceuticals, Sarepta Therapeutics, Nippon Shinyaku, BioNTech, Moderna Therapeutics, CureVac, Alnylam Pharmaceuticals, Regulus Therapeutics, Miragen Therapeutics, Mina Therapeutics, NeXstar Pharmaceuticals
遺伝病治療の進展, がん治療の新しいアプローチ, 心血管疾患に対する新規治療法
概要
本報告書は、核酸ベースの医薬品市場における製品タイプ、アプリケーション、主要プレーヤー、主要地域および国別の包括的な概要、市場シェア、および成長機会を示しています。
製品タイプによるセグメンテーション：
ASO（アプリストア最適化）
mRNA
siRNA
miRNA
saRNA
アプタマー
アプリケーション別のセグメンテーション：
遺伝性疾患
癌
心血管疾患
その他
この報告書は、地域別に市場を分割しています。
アメリカ合衆国
中国
ヨーロッパ
その他の地域：
日本
韓国
東南アジア
その他の地域
この報告書は、市場競争の状況や市場の主要プレーヤーに関する詳細な分析も提示しています。この報告書に含まれる主要プレーヤー：
アイオニス・ファーマシューティカルズ
サレプタ・セラピューティクス
日本新薬
バイオンテック
モダーナ・セラピューティクス
キュアバック
アルナイラム・ファーマシューティカルズ
レグルス・セラピューティクス
ミラゲン・セラピューティクス
ミナ・セラピューティクス
ネクスター・ファーマシューティカルズ
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 調査範囲
1.1 市場イントロダクション
1.2 対象年
1.3 調査目的
1.4 市場調査手法
1.5 調査プロセスとデータソース
1.6 経済指標
1.7 通貨
2 エグゼクティブサマリー
2.1 世界市場概要
2.1.1 グローバルの核酸医薬品市場規模、（2024年～2029年）
2.1.2 核酸医薬品市場規模、CAGR（地域別）
2.2 核酸医薬品セグメント、タイプ別
2.2.1 阿蘇
2.2.2 mRNA
2.2.3 siRNA
2.2.4 エムアールエヌエー
2.2.5
2.2.6 アプタマー
2.3 核酸医薬品市場規模：タイプ別
2.3.1 グローバルの核酸医薬品市場規模、市場シェア（タイプ別）（2024年～2029年）
2.3.2 グローバルの核酸医薬品市場規模、成長率（タイプ別）（2024年～2029年）
2.4 核酸医薬品セグメント、用途別
2.4.1 遺伝子疾患
2.4.2 がん種
2.4.3 循環器系疾患
2.4.4 その他
2.5 核酸医薬品市場規模：用途別
2.5.1 グローバルの核酸医薬品市場規模、市場シェア（用途別）（2024年～2029年）
2.5.2 グローバルの核酸医薬品市場規模、成長率（用途別）（2024年～2029年）
3 核酸医薬品主要企業
3.1 主要プレイヤーの核酸医薬品市場への参入日
3.2 主要プレーヤーの核酸医薬品製品
3.3
3.4 Funding/Investment
3.4.1 Funding/Investment、地域別
3.4.2 Funding/Investment、最終業界別
3.5 主要プレーヤーの核酸医薬品の評価額と時価総額
3.6 主要プレイヤーのM&A・事業拡大計画
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions
4 核酸医薬品、地域別
4.1 核酸医薬品市場規模（地域別）（2024年～2029年）
4.2 米国における核酸医薬品市場規模成長（2024年〜2029年）
4.3 中国における核酸医薬品市場規模成長（2024年〜2029年）
4.4 ヨーロッパにおける核酸医薬品市場規模成長（2024年〜2029年）
4.5 その他地域における核酸医薬品市場規模成長（2024年〜2029年）
5 米国
5.1 米国における核酸医薬品市場規模、タイプ別（2024年〜2029年）
5.2 米国における核酸医薬品市場規模、用途別（2024年〜2029年）
6 ヨーロッパ
6.1 ヨーロッパにおける核酸医薬品市場規模、タイプ別（2024年〜2029年）
6.2 ヨーロッパにおける核酸医薬品市場規模、用途別（2024年〜2029年）
7 中国
7.1 中国における核酸医薬品市場規模、タイプ別（2024年〜2029年）
7.2 中国における核酸医薬品市場規模、用途別（2024年〜2029年）
8 その他地域
8.1 その他地域における核酸医薬品市場規模、タイプ別（2024年〜2029年）
8.2 その他地域における核酸医薬品市場規模、用途別（2024年〜2029年）
8.3 日本
8.4 韓国
8.5 東南アジア
9 市場ドライバー・課題・トレンド
9.1 市場ドライバー・成長機会
9.2 市場課題・リスク
9.3 業界トレンド
10 核酸医薬品市場の主要投資家
10.1 Company A
10.1.1 Company A : 企業詳細
10.1.2 企業概要
10.1.3 A社の投資先
10.1.4 A社 主要開発と市場レイアウト
10.2 Company B
10.2.1 Company B : 企業詳細
10.2.2 企業概要
10.2.3 B社の投資先
10.2.4 B社 主要開発と市場レイアウト
10.3 Company C
10.3.1 Company C : 企業詳細
10.3.2 企業概要
10.3.3 C社の投資先
10.3.4 C社 主要開発と市場レイアウト
10.4 Company D
10.5 ……
11 キープレイヤー分析
11.1 Ionis Pharmaceuticals
11.1.1 Ionis Pharmaceuticals : 企業詳細
11.1.2 Ionis Pharmaceuticals：核酸医薬品分野の提供製品
11.1.3
11.1.4 Ionis Pharmaceuticals：主要事業概要
11.1.5 イオニス・ファーマシューティカルズ ニュース
11.2 Sarepta Therapeutics
11.2.1 Sarepta Therapeutics : 企業詳細
11.2.2 Sarepta Therapeutics：核酸医薬品分野の提供製品
11.2.3
11.2.4 Sarepta Therapeutics：主要事業概要
11.2.5 サレプタ・セラピューティクス ニュース
11.3 Nippon Shinyaku
11.3.1 Nippon Shinyaku : 企業詳細
11.3.2 Nippon Shinyaku：核酸医薬品分野の提供製品
11.3.3
11.3.4 Nippon Shinyaku：主要事業概要
11.3.5 日本新薬ニュース
11.4 BioNTech
11.4.1 BioNTech : 企業詳細
11.4.2 BioNTech：核酸医薬品分野の提供製品
11.4.3
11.4.4 BioNTech：主要事業概要
11.4.5 BioNTechニュース
11.5 Moderna Therapeutics
11.5.1 Moderna Therapeutics : 企業詳細
11.5.2 Moderna Therapeutics：核酸医薬品分野の提供製品
11.5.3
11.5.4 Moderna Therapeutics：主要事業概要
11.5.5 モデナ・セラピューティクス ニュース
11.6 CureVac
11.6.1 CureVac : 企業詳細
11.6.2 CureVac：核酸医薬品分野の提供製品
11.6.3
11.6.4 CureVac：主要事業概要
11.6.5 CureVacニュース
11.7 Alnylam Pharmaceuticals
11.7.1 Alnylam Pharmaceuticals : 企業詳細
11.7.2 Alnylam Pharmaceuticals：核酸医薬品分野の提供製品
11.7.3
11.7.4 Alnylam Pharmaceuticals：主要事業概要
11.7.5
11.8 Regulus Therapeutics
11.8.1 Regulus Therapeutics : 企業詳細
11.8.2 Regulus Therapeutics：核酸医薬品分野の提供製品
11.8.3
11.8.4 Regulus Therapeutics：主要事業概要
11.8.5 レグルス・セラピューティクス ニュース
11.9 Miragen Therapeutics
11.9.1 Miragen Therapeutics : 企業詳細
11.9.2 Miragen Therapeutics：核酸医薬品分野の提供製品
11.9.3
11.9.4 Miragen Therapeutics：主要事業概要
11.9.5
11.10 Mina Therapeutics
11.10.1 Mina Therapeutics : 企業詳細
11.10.2 Mina Therapeutics：核酸医薬品分野の提供製品
11.10.3
11.10.4 Mina Therapeutics：主要事業概要
11.10.5 ミナ・セラピューティクス ニュース
11.11 NeXstar Pharmaceuticals
12 調査の結果・結論
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Acid-based Drugs market by product type, application, key players and key regions and countries.
Segmentation by product type:
ASO
mRNA
siRNA
miRNA
saRNA
Aptamer
Segmentation by Application:
Genetic Disease
Cancer
Cardiovascular Diseases
Other
This report also splits the market by region:
United States
China
Europe
Other regions:
Japan
South Korea
Southeast Asia
Rest of world
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Ionis Pharmaceuticals
Sarepta Therapeutics
Nippon Shinyaku
BioNTech
Moderna Therapeutics
CureVac
Alnylam Pharmaceuticals
Regulus Therapeutics
Miragen Therapeutics
Mina Therapeutics
NeXstar Pharmaceuticals
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nucleic Acid-based Drugs Market Size 2024-2029
2.1.2 Nucleic Acid-based Drugs Market Size CAGR by Region
2.2 Nucleic Acid-based Drugs Segment by Type
2.2.1 ASO
2.2.2 mRNA
2.2.3 siRNA
2.2.4 miRNA
2.2.5 saRNA
2.2.6 Aptamer
2.3 Nucleic Acid-based Drugs Market Size by Type
2.3.1 Global Nucleic Acid-based Drugs Market Size Market Share by Type (2024-2029)
2.3.2 Global Nucleic Acid-based Drugs Market Size Growth Rate by Type (2024-2029)
2.4 Nucleic Acid-based Drugs Segment by Application
2.4.1 Genetic Disease
2.4.2 Cancer
2.4.3 Cardiovascular Diseases
2.4.4 Other
2.5 Nucleic Acid-based Drugs Market Size by Application
2.5.1 Global Nucleic Acid-based Drugs Market Size Market Share by Application (2024-2029)
2.5.2 Global Nucleic Acid-based Drugs Market Size Growth Rate by Application (2024-2029)
3 Nucleic Acid-based Drugs Key Players
3.1 Date of Key Players Enter into Nucleic Acid-based Drugs
3.2 Key Players Nucleic Acid-based Drugs Product Offered
3.3 Key Players Nucleic Acid-based Drugs Funding/Investment Analysis
3.4 Funding/Investment
3.4.1 Funding/Investment by Regions
3.4.2 Funding/Investment by End-Industry
3.5 Key Players Nucleic Acid-based Drugs Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions
4 Nucleic Acid-based Drugs by Regions
4.1 Nucleic Acid-based Drugs Market Size by Regions (2024-2029)
4.2 United States Nucleic Acid-based Drugs Market Size Growth (2024-2029)
4.3 China Nucleic Acid-based Drugs Market Size Growth (2024-2029)
4.4 Europe Nucleic Acid-based Drugs Market Size Growth (2024-2029)
4.5 Rest of World Nucleic Acid-based Drugs Market Size Growth (2024-2029)
5 United States
5.1 United States Nucleic Acid-based Drugs Market Size by Type (2024-2029)
5.2 United States Nucleic Acid-based Drugs Market Size by Application (2024-2029)
6 Europe
6.1 Europe Nucleic Acid-based Drugs Market Size by Type (2024-2029)
6.2 Europe Nucleic Acid-based Drugs Market Size by Application (2024-2029)
7 China
7.1 China Nucleic Acid-based Drugs Market Size by Type (2024-2029)
7.2 China Nucleic Acid-based Drugs Market Size by Application (2024-2029)
8 Rest of World
8.1 Rest of World Nucleic Acid-based Drugs Market Size by Type (2024-2029)
8.2 Rest of World Nucleic Acid-based Drugs Market Size by Application (2024-2029)
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Key Investors in Nucleic Acid-based Drugs
10.1 Company A
10.1.1 Company A Company Details
10.1.2 Company Description
10.1.3 Companies Invested by Company A
10.1.4 Company A Key Development and Market Layout
10.2 Company B
10.2.1 Company B Company Details
10.2.2 Company Description
10.2.3 Companies Invested by Company B
10.2.4 Company B Key Development and Market Layout
10.3 Company C
10.3.1 Company C Company Details
10.3.2 Company Description
10.3.3 Companies Invested by Company C
10.3.4 Company C Key Development and Market Layout
10.4 Company D
10.5 ……
11 Key Players Analysis
11.1 Ionis Pharmaceuticals
11.1.1 Ionis Pharmaceuticals Company Details
11.1.2 Ionis Pharmaceuticals Nucleic Acid-based Drugs Product Offered
11.1.3 Ionis Pharmaceuticals Nucleic Acid-based Drugs Market Size (2023 VS 2029)
11.1.4 Ionis Pharmaceuticals Main Business Overview
11.1.5 Ionis Pharmaceuticals News
11.2 Sarepta Therapeutics
11.2.1 Sarepta Therapeutics Company Details
11.2.2 Sarepta Therapeutics Nucleic Acid-based Drugs Product Offered
11.2.3 Sarepta Therapeutics Nucleic Acid-based Drugs Market Size (2023 VS 2029)
11.2.4 Sarepta Therapeutics Main Business Overview
11.2.5 Sarepta Therapeutics News
11.3 Nippon Shinyaku
11.3.1 Nippon Shinyaku Company Details
11.3.2 Nippon Shinyaku Nucleic Acid-based Drugs Product Offered
11.3.3 Nippon Shinyaku Nucleic Acid-based Drugs Market Size (2023 VS 2029)
11.3.4 Nippon Shinyaku Main Business Overview
11.3.5 Nippon Shinyaku News
11.4 BioNTech
11.4.1 BioNTech Company Details
11.4.2 BioNTech Nucleic Acid-based Drugs Product Offered
11.4.3 BioNTech Nucleic Acid-based Drugs Market Size (2023 VS 2029)
11.4.4 BioNTech Main Business Overview
11.4.5 BioNTech News
11.5 Moderna Therapeutics
11.5.1 Moderna Therapeutics Company Details
11.5.2 Moderna Therapeutics Nucleic Acid-based Drugs Product Offered
11.5.3 Moderna Therapeutics Nucleic Acid-based Drugs Market Size (2023 VS 2029)
11.5.4 Moderna Therapeutics Main Business Overview
11.5.5 Moderna Therapeutics News
11.6 CureVac
11.6.1 CureVac Company Details
11.6.2 CureVac Nucleic Acid-based Drugs Product Offered
11.6.3 CureVac Nucleic Acid-based Drugs Market Size (2023 VS 2029)
11.6.4 CureVac Main Business Overview
11.6.5 CureVac News
11.7 Alnylam Pharmaceuticals
11.7.1 Alnylam Pharmaceuticals Company Details
11.7.2 Alnylam Pharmaceuticals Nucleic Acid-based Drugs Product Offered
11.7.3 Alnylam Pharmaceuticals Nucleic Acid-based Drugs Market Size (2023 VS 2029)
11.7.4 Alnylam Pharmaceuticals Main Business Overview
11.7.5 Alnylam Pharmaceuticals News
11.8 Regulus Therapeutics
11.8.1 Regulus Therapeutics Company Details
11.8.2 Regulus Therapeutics Nucleic Acid-based Drugs Product Offered
11.8.3 Regulus Therapeutics Nucleic Acid-based Drugs Market Size (2023 VS 2029)
11.8.4 Regulus Therapeutics Main Business Overview
11.8.5 Regulus Therapeutics News
11.9 Miragen Therapeutics
11.9.1 Miragen Therapeutics Company Details
11.9.2 Miragen Therapeutics Nucleic Acid-based Drugs Product Offered
11.9.3 Miragen Therapeutics Nucleic Acid-based Drugs Market Size (2023 VS 2029)
11.9.4 Miragen Therapeutics Main Business Overview
11.9.5 Miragen Therapeutics News
11.10 Mina Therapeutics
11.10.1 Mina Therapeutics Company Details
11.10.2 Mina Therapeutics Nucleic Acid-based Drugs Product Offered
11.10.3 Mina Therapeutics Nucleic Acid-based Drugs Market Size (2023 VS 2029)
11.10.4 Mina Therapeutics Main Business Overview
11.10.5 Mina Therapeutics News
11.11 NeXstar Pharmaceuticals
12 Research Findings and Conclusion
List of Tables Table 1. Nucleic Acid-based Drugs Market Size CAGR by Region (2024-2029) ($ Millions) Table 2. Major Players of ASO Table 3. Major Players of mRNA Table 4. Major Players of siRNA Table 5. Major Players of miRNA Table 6. Major Players of saRNA Table 7. Major Players of Aptamer Table 8. Global Nucleic Acid-based Drugs Market Size by Type (2024-2029) ($ Millions) Table 9. Global Nucleic Acid-based Drugs Market Size Market Share by Type (2024-2029) Table 10. Global Nucleic Acid-based Drugs Market Size by Application (2024-2029) ($ Millions) Table 11. Global Nucleic Acid-based Drugs Market Size Market Share by Application (2024-2029) Table 12. Date of Global Key Players Enter into Nucleic Acid-based Drugs Market Table 13. Global Key Players Nucleic Acid-based Drugs Product Offered Table 14. Key Players Nucleic Acid-based Drugs Funding/Investment ($ Millions) Table 15. Funding/Investment by Regions Table 16. Funding/Investment by End Industry Table 17. Key Players Nucleic Acid-based Drugs Valuation & Market Capitalization ($ Millions) Table 18. Key Players Mergers & Acquisitions, Expansion Plans Table 19. Nucleic Acid-based Drugs New Product/Technology Launches Table 20. Nucleic Acid-based Drugs Industry Partnerships, Agreements, and Collaborations Table 21. Nucleic Acid-based Drugs Industry Mergers and Acquisitions Table 22. Global Nucleic Acid-based Drugs Market Size by Regions 2024-2029 ($ Millions) Table 23. Global Nucleic Acid-based Drugs Market Size Market Share by Regions 2024-2029 Table 24. United States Nucleic Acid-based Drugs Market Size by Type (2024-2029) ($ Millions) Table 25. United States Nucleic Acid-based Drugs Market Size Market Share by Type (2024-2029) Table 26. United States Nucleic Acid-based Drugs Market Size by Application (2024-2029) ($ Millions) Table 27. United States Nucleic Acid-based Drugs Market Size Market Share by Application (2024-2029) Table 28. Europe Nucleic Acid-based Drugs Market Size by Type (2024-2029) ($ Millions) Table 29. Europe Nucleic Acid-based Drugs Market Size Market Share by Type (2024-2029) Table 30. Europe Nucleic Acid-based Drugs Market Size by Application (2024-2029) ($ Millions) Table 31. Europe Nucleic Acid-based Drugs Market Size Market Share by Application (2024-2029) Table 32. China Nucleic Acid-based Drugs Market Size by Type (2024-2029) ($ Millions) Table 33. China Nucleic Acid-based Drugs Market Size Market Share by Type (2024-2029) Table 34. China Nucleic Acid-based Drugs Market Size by Application (2024-2029) ($ Millions) Table 35. China Nucleic Acid-based Drugs Market Size Market Share by Application (2024-2029) Table 36. Rest of World Nucleic Acid-based Drugs Market Size by Type (2024-2029) ($ Millions) Table 37. Rest of World Nucleic Acid-based Drugs Market Size Market Share by Type (2024-2029) Table 38. Rest of World Nucleic Acid-based Drugs Market Size by Application (2024-2029) ($ Millions) Table 39. Rest of World Nucleic Acid-based Drugs Market Size Market Share by Application (2024-2029) Table 40. Key Market Drivers & Growth Opportunities of Nucleic Acid-based Drugs Table 41. Key Market Challenges & Risks of Nucleic Acid-based Drugs Table 42. Key Industry Trends of Nucleic Acid-based Drugs Table 43. Company A Company Details Table 44. Companies Invested by Company A Table 45. Company A Key Development and Market Layout Table 46. Company B Company Details Table 47. Companies Invested by Company B Table 48. Company B Key Development and Market Layout Table 49. Company C Company Details Table 50. Companies Invested by Company C Table 51. Company C Key Development and Market Layout Table 52. Company C Company Details Table 53. Companies Invested by Company C Table 54. Company C Key Development and Market Layout Table 55. Ionis Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors Table 56. Ionis Pharmaceuticals Nucleic Acid-based Drugs Market Size (2023 VS 2029) Table 57. Sarepta Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors Table 58. Sarepta Therapeutics Nucleic Acid-based Drugs Market Size (2023 VS 2029) Table 59. Nippon Shinyaku Basic Information, Head Office, Major Market Areas and Its Competitors Table 60. Nippon Shinyaku Nucleic Acid-based Drugs Market Size (2023 VS 2029) Table 61. BioNTech Basic Information, Head Office, Major Market Areas and Its Competitors Table 62. BioNTech Nucleic Acid-based Drugs Market Size (2023 VS 2029) Table 63. Moderna Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors Table 64. Moderna Therapeutics Nucleic Acid-based Drugs Market Size (2023 VS 2029) Table 65. CureVac Basic Information, Head Office, Major Market Areas and Its Competitors Table 66. CureVac Nucleic Acid-based Drugs Market Size (2023 VS 2029) Table 67. Alnylam Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors Table 68. Alnylam Pharmaceuticals Nucleic Acid-based Drugs Market Size (2023 VS 2029) Table 69. Regulus Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors Table 70. Regulus Therapeutics Nucleic Acid-based Drugs Market Size (2023 VS 2029) Table 71. Miragen Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors Table 72. Miragen Therapeutics Nucleic Acid-based Drugs Market Size (2023 VS 2029) Table 73. Mina Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors Table 74. Mina Therapeutics Nucleic Acid-based Drugs Market Size (2023 VS 2029) Table 75. NeXstar Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors Table 76. NeXstar Pharmaceuticals Nucleic Acid-based Drugs Market Size (2023 VS 2029) List of Figures Figure 1. Picture of Nucleic Acid-based Drugs Figure 2. Nucleic Acid-based Drugs Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Nucleic Acid-based Drugs Market Size Growth Rate 2024-2029 ($ Millions) Figure 7. Nucleic Acid-based Drugs Market Size by Region (2023 & 2029) ($ millions) Figure 8. Global Nucleic Acid-based Drugs Market Size Market Share by Type (2024-2029) Figure 9. Global ASO Market Size Growth Rate Figure 10. Global mRNA Market Size Growth Rate Figure 11. Global siRNA Market Size Growth Rate Figure 12. Global miRNA Market Size Growth Rate Figure 13. Global saRNA Market Size Growth Rate Figure 14. Global Aptamer Market Size Growth Rate Figure 15. Nucleic Acid-based Drugs in Genetic Disease Figure 16. Global Nucleic Acid-based Drugs Market: Genetic Disease (2024-2029) ($ Millions) Figure 17. Nucleic Acid-based Drugs in Cancer Figure 18. Global Nucleic Acid-based Drugs Market: Cancer (2024-2029) ($ Millions) Figure 19. Nucleic Acid-based Drugs in Cardiovascular Diseases Figure 20. Global Nucleic Acid-based Drugs Market: Cardiovascular Diseases (2024-2029) ($ Millions) Figure 21. Nucleic Acid-based Drugs in Other Figure 22. Global Nucleic Acid-based Drugs Market: Other (2024-2029) ($ Millions) Figure 23. Global Nucleic Acid-based Drugs Market Size Market Share by Application (2024-2029) Figure 24. Global Nucleic Acid-based Drugs Market Size in Genetic Disease Growth Rate Figure 25. Global Nucleic Acid-based Drugs Market Size in Cancer Growth Rate Figure 26. Global Nucleic Acid-based Drugs Market Size in Cardiovascular Diseases Growth Rate Figure 27. Global Nucleic Acid-based Drugs Market Size in Other Growth Rate Figure 28. Funding/Investment Figure 29. Global Nucleic Acid-based Drugs Market Size Market Share by Regions 2024-2029 Figure 30. United States Nucleic Acid-based Drugs Market Size 2024-2029 ($ Millions) Figure 31. China Nucleic Acid-based Drugs Market Size 2024-2029 ($ Millions) Figure 32. Europe Nucleic Acid-based Drugs Market Size 2024-2029 ($ Millions) Figure 33. Rest of World Nucleic Acid-based Drugs Market Size 2024-2029 ($ Millions) Figure 34. United States Nucleic Acid-based Drugs Consumption Market Share by Type in 2029 Figure 35. United States Nucleic Acid-based Drugs Market Size Market Share by Application in 2029 Figure 36. China Nucleic Acid-based Drugs Consumption Market Share by Type in 2029 Figure 37. China Nucleic Acid-based Drugs Market Size Market Share by Application in 2029 Figure 38. Europe Nucleic Acid-based Drugs Consumption Market Share by Type in 2029 Figure 39. Europe Nucleic Acid-based Drugs Market Size Market Share by Application in 2029 Figure 40. Rest of World Nucleic Acid-based Drugs Consumption Market Share by Type in 2029 Figure 41. Rest of World Nucleic Acid-based Drugs Market Size Market Share by Application in 2029
